Albany, NY -- (SBWIRE) -- 05/05/2015 -- Data from a new report published by Transparency Market Research "U.S. Vaccine Market - U.S. Industry Analysis, Size, Share, Growth, And Forecast, 2012 - 2018", estimates the U.S. vaccine market to be worth USD 12.8 billion in 2012 and further expected to reach USD 17.4 billion by 2018, growing at a CAGR of 5.3% from 2012 to 2018.

Vaccines for different disorders and illnesses are included among the leading earners in the pharmaceutical industry. Over the recent years, enhanced research and development in this market has led to the production of better-quality and effective drugs and vaccines to treat various illnesses. The vaccine sales in U.S. are growing rapidly at a faster rate as compared to the other prescription medicines in the market. U.S. has showed a substantial revenue growth in the vaccine production market increasing the enormity of this industry as well.

Browse Full Report with TOC: http://www.transparencymarketresearch.com/us-vaccine-market.html

The vaccine sales are chiefly resistive to the generic competition that is quoting drug makers billions of dollars in revenues on each of their top-selling vaccine treatments. Moreover, government supporting agencies are unfailing buyers of the vaccine products both in the U.S., as well as across the globe. Hence, U.S. is focused on continuing to lead the global vaccine market amongst other markets in the world. This drive is also due to the rising prevalence of infectious diseases in animals and humans, and improvements seen in the biotechnology sector across U.S.

According to the industry best market research firms' surveys, many U.S. pediatricians claimed that over half of the U.S. population have parental concerns about general vaccines and child immunization. It is for such reasons, pediatric vaccine segment in the U.S. human vaccine market takes pride in holding the highest market share, as well as high growth rate because of government compulsion for child immunization. The adult & adolescent vaccine market in the

U.S. is expected to grow judiciously over the next six years due to increasing awareness for human papillomavirus (HPV) and other viral diseases.

On the other hand, the livestock vaccine is another leading segment across the U.S. Due to an increased awareness towards protecting infectious diseases in cattle, rising vaccination to prevent breeding animals against illnesses and disorders, and organizing the entire dairy sector, this market accounted for 58.1% of the total shares in 2012. The Bovine vaccine sector in the United States is considered to be the largest revenue generating sector in the present day.

Enquiry Before Buying: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=553

However, in 2011, the feline vaccine and canine vaccine also accounted for approximately 95.1% shares in the overall U.S. companion animal vaccine market.

This report includes more information about the generalized overview of the U.S. vaccine market including definitions, applications, and global market industry structure. It discusses the ephemeral shelf-life of certain vaccines available in the market and how they will have a negative impact on the overall market size and growth. However, the report also includes the market analysis of the overall vaccine industry that has multinational firms working on huge product pipeline in order to overcome all the shortcomings and restraints. The report provides extensive analysis of the U.S. vaccine market and the factors that will further revolutionize this industry towards a massive growth.

Among all the geographical regions, U.S. Vaccine Market is considered to be the largest in the history of vaccine. Since 2011, there have been some significant leading producers of human vaccine for the U.S. market and the names included are Merck, Sanofi-Aventis, Pfizer, GlaxoSmithKline, Sanofi-Pasture and Novartis. Similarly, for the animal vaccine market, the leading producers of animal vaccine for the U.S. market includes Merial (Sanofi-Aventis), Pfizer Animal Health, Novartis Animal Health, and Intervet/Schering-Plough (Merck).

Read Full Article @ http://www.transparencymarketresearch.com/article/us-vaccine-market.htm

About Transparency Market Research
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: 518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Browse The Market Research Blog :
https://marketsresearchindustry.wordpress.com/